Company: VCYT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0001384101-25-000014
Chunk: 168

Company: VERACYTE, INC.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 168
---
 stock units1,672 2 17,105 — — 17,107 Issuance of common stock under ESPP138 — 2,886 — — 2,886 Tax portion of vested restricted stock units— — (10,589)— — (10,589)Stock-based compensation expense (employee)— — 34,919 — — 34,919 Stock-based compensation expense (ESPP)— — 1,330 — — 1,330 Net income— — — 24,138 — 24,138 Comprehensive loss— — — — (12,072)(12,072)Balance at December 31, 202477,773 $78 $1,655,961 $(443,983)$(36,090)$1,175,966 

  The accompanying notes are an integral part of these consolidated financial statements.

87

VERACYTE, INC.

Consolidated Statements of Cash Flows

(in thousands of dollars)

 Year Ended December 31, 202420232022Operating activities   Net income (loss)$24,138 $(74,404)$(36,560)Adjustments to reconcile net income (loss) to net cash provided by operating activities:   Depreciation and amortization23,459 27,188 25,928 Loss on disposal of property, plant and equipment202 271 206 Stock-based compensation36,249 33,141 26,734 Deferred income taxes(233)(3,839)133 Interest on end-of-term debt obligation— — 161 Noncash lease expense4,955 4,158 3,320 Revaluation of acquisition-related contingent consideration2,167 (5,383)154 Impairment loss3,368 68,349 3,318 Effect of foreign currency on operations2,110 (1,096)522 Changes in operating assets and liabilities:   Accounts receivable(6,405)3,887 (4,495)Supplies and inventory(5,871)(1,694)(3,011)Prepaid expenses and other current assets(1,296)(458)1,390 Other assets(1,576)(758)(3,049)Operating lease liability(5,407)(4,330)(3,448